Cargando…
Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer’s Disease after Ischemia-Reperfusion Brain Injury
Recent evidence suggests that transient ischemia of the brain with reperfusion in humans and animals is associated with the neuronal accumulation of neurotoxic molecules associated with Alzheimer’s disease, such as all parts of the amyloid protein precursor and modified tau protein. Pathological cha...
Autores principales: | Ułamek-Kozioł, Marzena, Czuczwar, Stanisław Jerzy, Januszewski, Sławomir, Pluta, Ryszard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037789/ https://www.ncbi.nlm.nih.gov/pubmed/32019137 http://dx.doi.org/10.3390/ijms21030892 |
Ejemplares similares
-
Shared Genomic and Proteomic Contribution of Amyloid and Tau Protein Characteristic of Alzheimer’s Disease to Brain Ischemia
por: Pluta, Ryszard, et al.
Publicado: (2020) -
Tau Protein Dysfunction after Brain Ischemia
por: Pluta, Ryszard, et al.
Publicado: (2018) -
Participation of Amyloid and Tau Protein in Neuronal Death and Neurodegeneration after Brain Ischemia
por: Pluta, Ryszard, et al.
Publicado: (2020) -
Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia
por: Ułamek-Kozioł, Marzena, et al.
Publicado: (2020) -
Gut microbiota and pro/prebiotics in Alzheimer’s disease
por: Pluta, Ryszard, et al.
Publicado: (2020)